Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma, Ewing × Dactinomycin × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Cyclophosphamide 6 Topotecan 5 Melphalan 5 Busulfan 5 Temozolomide 4 Irinotecan 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 liposomal doxorubicin 3 fludarabine phosphate 3 fludarabine 3 cabozantinib 3 regorafenib 2 pegfilgrastim 2 Vincristine 2 Sirolimus 2 Bone Marrow Transplantation 2 trioctyl phosphine oxide 1 thymoglobulin 1 talazoparib 1 selinexor 1 seclidemstat 1 racotumomab 1 poly ICLC 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olaparib 1 niraparib 1 lexatumumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07194044 2026-03-16

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡